Transcript lecture2
a single gene defect causes
a clinically significant block in a
metabolic pathway resulting either in
accumulation of substrate behind the
block or deficiency of the product
IEM arises from a damaged gene which
leads to abnormal enzyme.
May be autosomal or sex-linked.
May be recessive or dominant in
expression.
Heterozygote will have both normal and
abnormal alleles. But homozygote will
have two alleles the same on each
chromosome.
An accumulation of the substrate before the enzyme
defect*.
A decrease in the amount of the product is observed.
An increased concentration of the alternative
metabolites*.
A decrease or absence of the enzyme activity.
Screening for IEM who do not have the
symptoms
Investigations of the patient with
symptoms of the IEM
It is the process of detecting a patient
with an IEM before they show overt
symptoms of the disease.
› Allow the treatment to begin
› Counseling to be given
Screening is done for high risk group which
includes
All newborn infants
Family of affected children
Expectant mothers who have history of
affected children. (prenatal diagnosis)
Suitable treatment for disease
Life threatening disease
High incidence of disease
A suitable test is available
Acceptable cost.
› PKU
› Congenital hypothyroidism
Test to identify carriers of the disease
Failure to thrive
Poor feeding
Persistent vomiting
Unexplained jaundice
Unexplained hypoglycemia
Ketosis
Lactic acidosis
Convulsions and coma
Lethargy
Hypotonia
hyperventilation
Some may present later (within first few
years)
› Abnormal liver function tests
› Mental retardation
Front line tests
Plasma
›
›
›
›
›
›
Electrolytes
Acid base balance
Blood gases
Glucose
Liver function tests
calcium
Plasma
› Insulin
› Lactic acid
› Ammonia
› Ketones
Urine
› Amino acids
› Organic acids
› Sugars
History of affected individual
› Amniocentesis (15th week of gestation -20th
week)
fibroblast extracted from amniotic fluid.
fibroblasts are cultured and specific enzyme
studies are done
Cvs (9th week completed within 10 days)
›
›
›
›
DNA analysis (cystic fibrosis)
Down syndrome
Hemoglobinopathies
Tay sachs disaease
Autosomal recessive disorder
1 in 15,000 live births in America.
Deficiency of phenylalanine hydroxylase
Deficiency
May be carried out in three stages:
a. Diagnosis of Broad Category: Saudubray
et al (2002)* suggested a battery of simple
and routine tests for identification of the
broad category of the disorders. These tests
include plasma electrolytes, ABGs, blood
ammonia and lactic acid etc.
*Saudubray JM, Nasoogne MC, Lonlay PD, Touati G. Clinical approach to
inherited metabolic disorders in neonates: an overview. Smin Neonatol 2002; 7: 3-15.
May be carried out in three stages:
b. Diagnosis of the exact disorder
• It requires very sophisticated equipment
e.g. HPLC, tandem mass spectrometry,
GC-MS and ion exchange
chromatography.
May be carried out in three stages:
b. Diagnosis of the exact disorder (cont)
• These techniques also require elaborate
infrastructure of trained manpower,
proper back-up service for the
instruments and regular supply of
reagents.
May be carried out in three stages:
b. Diagnosis of the exact disorder (cont)
• AKU hospital has taken an initiative to
establish the first-ever lab in the country
for the pin-point diagnosis of some of the
IEM.
May be carried out in three stages:
c. Determination of deficient enzyme or
protein Although a few laboratories in the
world provide this facility, this is only of
academic and research interest. Diagnosis of
the genetic defect provides another
promising pathway for some of these
disorders.